Your browser doesn't support javascript.
loading
Prognostic value of the revised International Prognostic Scoring System five-group cytogenetic abnormality classification for the outcome prediction of hematopoietic stem cell transplantation in pediatric myelodysplastic syndrome.
Yamamoto, Shohei; Kato, Motohiro; Watanabe, Kenichiro; Ishimaru, Sae; Hasegawa, Daisuke; Noguchi, Maiko; Hama, Asahito; Sato, Maho; Koike, Takashi; Iwasaki, Fuminori; Yagasaki, Hiroshi; Takahashi, Yoshiyuki; Kosaka, Yoshiyuki; Hashii, Yoshiko; Morimoto, Akira; Atsuta, Yoshiko; Hasegawa, Daiichiro; Yoshida, Nao.
Afiliação
  • Yamamoto S; Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Kanagawa, Japan. shohei-y@tsc.u-tokai.ac.jp.
  • Kato M; Department of Pediatrics, Showa University Fujigaoka Hospital, Kanagawa, Japan. shohei-y@tsc.u-tokai.ac.jp.
  • Watanabe K; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Ishimaru S; Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
  • Hasegawa D; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Noguchi M; Department of Pediatrics, St Luke's International Hospital, Tokyo, Japan.
  • Hama A; Department of Pediatrics, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Sato M; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Aichi, Japan.
  • Koike T; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
  • Iwasaki F; Division of Cell Transplantation, Tokai University School of Medicine, Kanagawa, Japan.
  • Yagasaki H; Division of Hemato-Oncology/Regenerative Medicine, Kanagawa Children's Medical Center, Kanagawa, Japan.
  • Takahashi Y; Department of Pediatrics and Child Health, Nihon University Itabashi Hospital, Tokyo, Japan.
  • Kosaka Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Hashii Y; Department of Hematology and Oncology, Center of Childhood Cancer, Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan.
  • Morimoto A; Cancer Immunotherapy/Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Atsuta Y; Department of Pediatrics, Jichi Medical University School of Medicine, Tochigi, Japan.
  • Hasegawa D; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.
  • Yoshida N; Department of Hematology and Oncology, Center of Childhood Cancer, Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan.
Bone Marrow Transplant ; 56(12): 3016-3023, 2021 12.
Article em En | MEDLINE | ID: mdl-34508178
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido